Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Involvement of exon 11-associated variants of the mu opioid receptor MOR-1 in heroin, but not morphine, actions.

http://www.ncbi.nlm.nih.gov/pubmed/19273844

Heroin remains a major drug of abuse and is preferred by addicts over morphine. Like morphine, heroin has high affinity and selectivity for mu-receptors, but its residual analgesia in exon 1 MOR-1 knockout mice that do not respond to morphine suggests a different mechanism of action. MOR-1 splice variants lacking exon 1 have been observed in mice, humans, and rats, raising the possibility that they might be responsible for the residual heroin and morphine-6beta-glucuronide (M6G) analgesia in the exon 1 knockout mice. To test this possibility, we disrupted exon 11 of MOR-1, which eliminates all of the variants that do not contain exon 1. Morphine and methadone analgesia in the exon 11 knockout mouse was normal, but the analgesic actions of heroin, M6G, and fentanyl were markedly diminished in the radiant heat tail-flick and hot-plate assays. Similarly, the ability of M6G to inhibit gastrointestinal transit was greatly diminished in these exon 11 knockout mice, whereas the ability of morphine was unchanged. These findings identify receptors selectively involved with heroin and M6G actions and confirm the relevance of the exon 11-associated variants and raise important issues regarding the importance of atypical truncated G-protein-coupled receptors.

Pubmed ID: 19273844 RIS Download

Mesh terms: Alternative Splicing | Analgesia | Animals | Exons | Gastrointestinal Transit | Gene Targeting | Heroin | Heterozygote | Mice | Mice, Knockout | Morphine | Mutation | Naloxone | Naltrexone | Receptors, Opioid, mu

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, Id: CA08748
  • Agency: NIDA NIH HHS, Id: DA02165
  • Agency: NIDA NIH HHS, Id: DA06241
  • Agency: NIDA NIH HHS, Id: DA07242
  • Agency: NIDA NIH HHS, Id: DA13997
  • Agency: NIDA NIH HHS, Id: K05DA00220
  • Agency: NCI NIH HHS, Id: P30 CA008748
  • Agency: NIDA NIH HHS, Id: R01 DA007242
  • Agency: NIDA NIH HHS, Id: R01 DA013997
  • Agency: NIDA NIH HHS, Id: R21 DA029244
  • Agency: NIDA NIH HHS, Id: R56 DA002615

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.